RASNA THERAPEUTICS, INC. (OTCMKTS:RASP) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

13

RASNA THERAPEUTICS, INC. (OTCMKTS:RASP) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On October 11, 2017, the Board of Directors of Rasna Therapeutics, Inc. (“Company”) adopted a resolution to change the Company’s fiscal year end from March 31 to September 30, effective immediately as of the date of the board resolution. The Company will file its transition report on Form 10-K.


About RASNA THERAPEUTICS, INC. (OTCMKTS:RASP)

Rasna Therapeutics, Inc., formerly Active With Me Inc., creates online resources that offer travelers information on activity-based travel. The Company’s Website focuses on offering third-party content and information to visitors in their activity of choice. The Company’s Website also focuses on offering links to clubs and organizations. The Company is in development-stage. Rasna DE is the subsidiary of the Company. Rasna DE is engaged in modulating the molecular targets nucleophosmin gene (NPM1) and lysine (K)-specific demethylase 1A (LSD1), which are implicated in the disease progression of leukemia and lymphoma. The Company focuses on performing preclinical research on NPM1 and LSD1. As of June 30, 2016, the Company had not generated any revenues.

An ad to help with our costs